文献速递乳腺癌

乳腺癌患者术前放疗:32年随访

Preoperative radiotherapy in breast cancer patients: 32 years of follow-up.
PubMed 文献 · Eur J Cancer · 2017-03-06

本研究回顾性分析187例接受根治性乳房切除术前放疗的乳腺癌患者,中位随访32年,25年局部区域控制率为89%,无病生存率和总生存率均为30%;肿瘤和淋巴结病理完全缓解率10%,三阴性患者为26%,三阴性状态是病理完全缓解的唯一预测因素。术前放疗后根治性手术可行且长期局部区域控制良好。

要点

  • 25年局部区域控制率89%,无病生存率和总生存率均为30%。
  • 全组病理完全缓解率10%,三阴性患者为26%。
  • 三阴性状态是病理完全缓解的唯一预测因素(OR=5.49)。

核心结论

  • 术前放疗后根治性手术可行,并与良好的长期局部区域控制相关。

研究设计与样本

  • 回顾性队列研究,纳入187例接受根治性乳房切除术前放疗的乳腺癌患者,中位年龄49岁[43-60],肿瘤为T2-T4或N2。
  • 1970年至1984年间,患者接受全乳、同侧锁骨上区和腋窝±内乳链的稍低分割放疗(45-55 Gy/18次,每次2.5 Gy/34天),随后系统性地行改良根治性乳房切除术加腋窝清扫。
  • 未给予其他术前治疗。

主要发现

  • 中位随访32年[23-35]。
  • 25年局部区域控制率为89%[93%-82%],25年无病生存率和总生存率相同,均为30%[24%-37%]。
  • 在所有患者中,18例(10%)达到肿瘤和淋巴结病理完全缓解,三阴性患者中为26%。
  • 多因素分析中,三阴性状态是病理完全缓解的唯一预测因素(OR=5.49,95%CI 1.87-16.1,p=0.002)。
  • pN状态(HR=1.69,[1.28-2.22],p=0.0002)和三阴性亚型(HR=1.80,[1.00-3.26],p=0.05)对总生存有显著预后影响。

关键数值与推荐

  • 在166例中心复核的肿瘤活检标本中,22%为三阴性表型,17%为HER2 3+或扩增,61%为ER+。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This study evaluates the long-term outcomes of a retrospective cohort of breast cancer (BC) patients who had received curatively intended premastectomy radiation therapy (RT). We analysed locoregional control, disease-free survival (DFS) and overall survival (OS), pathological complete remission (pCR), predictors thereof, and immediate safety. The series consisted of 187 patients with a median age of 49 years [43-60] and T2-T4 or N2 tumours. Between 1970 and 1984, they had received slightly hypofractionated RT to the whole breast, ipsilateral supraclavicular fossa and axilla ± the internal mammary chain (45-55 Gy/18 fractions of 2.5 Gy/34 days) systematically followed by a modified radical mastectomy with an axillary dissection. No other preoperative treatment was given. Among the 166 centrally reviewed tumour biopsy specimens, 22% had a triple-negative (TN) phenotype, 17% were HER2 3 + or amplified and 61% were ER+. The median follow-up was 32 years [23-35]. The 25-year locoregional control rate was 89% [93%-82%] and the 25-year DFS and OS rates were identical, 30% [24%-37%]. A pCR in the tumour and lymph nodes had been achieved in 18 among all patients (10%), but in 26% with TN disease. In the multivariate analysis, the TN status was the only predictive factor of pCR (OR = 5.49, 95% confidence interval [CI] 1.87-16.1, p = 0.002). Also, the pN status (HR = 1.69, [1.28-2.22], p = 0.0002) and TN subtype (HR = 1.80, [1.00-3.26], p = 0.05) exerted a significant prognostic impact on OS. The postoperative complication rate (grade >2) was 19% with 4.3% of localized skin necrosis. Preoperative RT followed by radical surgery is feasible and associated with good long-term locoregional control.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Riet FG, Fayard F, Arriagada R, et al. Preoperative radiotherapy in breast cancer patients: 32 years of follow-up. Eur J Cancer. 2017. PMID: 28267657. doi:10.1016/j.ejca.2017.01.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。